KIRKLAND, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the launch of its initial public offering of 10,000,000 common shares.
In addition, the underwriters will have a 30-day over-allotment option to purchase up to 1,500,000 additional common shares from Kestra at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $14.00 and $16.00 per common share. Kestra has applied to list its common shares on the Nasdaq Global Select Market under the ticker symbol “KMTS.”
BofA Securities, Goldman Sachs and Piper Sandler are acting as lead bookrunners for the proposed offering. Wells Fargo Securities and Stifel are acting as bookrunners and Wolfe | Nomura Alliance …
Full story available on Benzinga.com
KIRKLAND, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the launch of its initial public offering of 10,000,000 common shares.
In addition, the underwriters will have a 30-day over-allotment option to purchase up to 1,500,000 additional common shares from Kestra at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $14.00 and $16.00 per common share. Kestra has applied to list its common shares on the Nasdaq Global Select Market under the ticker symbol “KMTS.”
BofA Securities, Goldman Sachs and Piper Sandler are acting as lead bookrunners for the proposed offering. Wells Fargo Securities and Stifel are acting as bookrunners and Wolfe | Nomura Alliance …
Full story available on Benzinga.com
KIRKLAND, Wash., Feb. 26, 2025 (GLOBE NEWSWIRE) — Kestra Medical Technologies, Ltd. (“Kestra”), a wearable medical device and digital healthcare company, today announced the launch of its initial public offering of 10,000,000 common shares.
In addition, the underwriters will have a 30-day over-allotment option to purchase up to 1,500,000 additional common shares from Kestra at the initial public offering price, less underwriting discounts and commissions. The initial public offering price is expected to be between $14.00 and $16.00 per common share. Kestra has applied to list its common shares on the Nasdaq Global Select Market under the ticker symbol “KMTS.”
BofA Securities, Goldman Sachs and Piper Sandler are acting as lead bookrunners for the proposed offering. Wells Fargo Securities and Stifel are acting as bookrunners and Wolfe | Nomura Alliance …Full story available on Benzinga.com Read MoreKMTS, News, IPOs, Press Releases IPOs
